22nd Annual Pharmaceutical & Medical Device Compliance Congress

Special Closed-Door Session- Invitation Only Chief Compliance Officer Round Table Hosted by Pharmaceutical Compliance Forum Tuesday, November 2, 2021 1:00-4:00pm Please Note: Live Attendance Is Required. The Roundtable Will Not Be Recorded Welcome- PCF Co-Chairs 1:00-1:10 pm Joseph Zimmerman (Chair), Vice President, Chief Compliance Officer & Privacy Officer, Ferring Pharmaceuticals Indrani Franchini, JD, Formerly Executive … Read more

FDA Enforcement and Litigation conference – Scheduled panel speaker 12/10/21

Updates for 2021 FDLI remains committed to providing high-quality educational programs while keeping our members and event attendees safe during the current pandemic. With this in mind, we are excited to announce that the 2021 Enforcement, Litigation, and Compliance Conference will be a virtual event. Please know we are actively exploring options to ensure an … Read more

Successful Use of Inter Partes Review to Cancel Claims Asserted in Parallel Litigation

In a trio of March 6, 2014 inter partes review (IPR) decisions, the Patent Trial and Appeal Board (PTAB) canceled patent claims related to next generation DNA sequencing technology, after Illumina, Inc. countered Columbia University’s patent infringement suit by successfully petitioning for IPR of claims in three of five of Columbia’s patents-in-suit. The decisions illustrate … Read more

.C. Circuit’s July 27 decision in Friedman v. Sebelius upholds HHS order excluding

In a trio of March 6, 2014 inter partes review (IPR) decisions, the Patent Trial and Appeal Board (PTAB) canceled patent claims related to next generation DNA sequencing technology, after Illumina, Inc. countered Columbia University’s patent infringement suit by successfully petitioning for IPR of claims in three of five of Columbia’s patents-in-suit. The decisions illustrate … Read more

Practice Group’s latest newsletter, including my article on an FDA-friendly

In a trio of March 6, 2014 inter partes review (IPR) decisions, the Patent Trial and Appeal Board (PTAB) canceled patent claims related to next generation DNA sequencing technology, after Illumina, Inc. countered Columbia University’s patent infringement suit by successfully petitioning for IPR of claims in three of five of Columbia’s patents-in-suit. The decisions illustrate … Read more

Challenges of bringing mHealth products to the market are highlighted in Duane

In a trio of March 6, 2014 inter partes review (IPR) decisions, the Patent Trial and Appeal Board (PTAB) canceled patent claims related to next generation DNA sequencing technology, after Illumina, Inc. countered Columbia University’s patent infringement suit by successfully petitioning for IPR of claims in three of five of Columbia’s patents-in-suit. The decisions illustrate … Read more

Court Offers Insights On When the 271(e)(1) Safe Harbor Applies to the Use of Patented

In a trio of March 6, 2014 inter partes review (IPR) decisions, the Patent Trial and Appeal Board (PTAB) canceled patent claims related to next generation DNA sequencing technology, after Illumina, Inc. countered Columbia University’s patent infringement suit by successfully petitioning for IPR of claims in three of five of Columbia’s patents-in-suit. The decisions illustrate … Read more

ex-Purdue Pharma executives–including ex-General Counsel–from federal

In a trio of March 6, 2014 inter partes review (IPR) decisions, the Patent Trial and Appeal Board (PTAB) canceled patent claims related to next generation DNA sequencing technology, after Illumina, Inc. countered Columbia University’s patent infringement suit by successfully petitioning for IPR of claims in three of five of Columbia’s patents-in-suit. The decisions illustrate … Read more

Enforcement, Litigation, and Compliance Conference

For the Drug, Device, Food, and Tobacco Industries Conference Agenda We are going virtual! To promote optimal interaction between attendees, the conference will include ample audience participation and opportunities to connect with your peers between sessions. Agenda Subject to Change | All Times are Eastern Time Top Trends and Cases in FDA and DOJ Criminal … Read more

Annual CBI West Coast Compliance Congress- Guest Speaker -2015 -Utilize Data to Inform Risk-Based Auditing and Monitoring Practices

CBI’s Sixth Annual West Coast Compliance Congress will take place November 5-6, 2015 at the Hyatt Fisherman’s Wharf in San Francisco, California. This year’s West Coast Compliance Congress is in a new format that allows attendees to customize their experience and learning opportunities, depending on their field and interests. This year’s Compliance Congress boasts over forty speakers representing … Read more